• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bavarian Nordic A/S

+ Add to Watchlist


13.2500 USD 0.00000.00%

As of 20:10:00 ET on 09/08/2014.

Snapshot for Bavarian Nordic A/S (BVNKF)

Open: - Day's Range: - Volume: 225
Previous Close: 13.2500 52wk Range: 12.2000 - 23.4300 1-Yr Rtn: -

Stock Chart for BVNKF

No chart data available.
  • BVNKF:US 13.2500
  • 1D
  • 1M
  • 1Y
Interactive BVNKF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BVNKF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 609.7756
Relative P/E vs. SPX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 0.1250
Est. PEG Ratio -
Market Cap (M USD) 346.00
Shares Outstanding (M) 26.11
30 Day Average Volume 76
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BVNKF

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for BVNKF

Bavarian Nordic A/S is a biotechnology company developing and producing vaccines for the treatment and prevention of cancer and infectious diseases. The company also manufactures and delivers modern smallpox vaccines for governments under national emergency rules.

Gerard W M Van OdijkChairmanPaul ChaplinPresident/CEO
James B Breitmeyer "Jim"Pres:Cancer/Exec VPOle LarsenExec VP/CFO
More Company Profile & Key Executives for BVNKF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil